Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIGANT: ELIGARD Safety Study in Asian Prostate Cancer Patients
NCT03035032Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2017
- Primary completion
- Nov 2019
- Modality
- Peptides, Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of leuprolide in prostate cancer (PCa), sponsored by Astellas Pharma. Started Jun 2017; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03035032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03035032.